The U.S. Food and Drug Administration (FDA) announced its latest efforts in supporting the Bonn Call for Action, an international list of priorities for radiation protection in medicine for the next decade.
If you enjoy this content, please share it with a colleague
Voyant Health, a Brainlab company, announced that it has received U.S. Food and Drug Administration (FDA) clearance on TraumaCad Mobile, a mobile solution for pre-operative orthopedic surgical planning and digital templating.
Two new studies from the University of Virginia School of Medicine have cast doubt on the wisdom of delaying radiation treatment for prostate cancer as long as possible after the removal of the prostate. The pervading belief is that doing so helps prevent unwanted side effects.
If you enjoy this content, please share it with a colleague
Brainlab announced first patient treatments on a fully integrated radiation oncology solution that combines ExacTrac patient positioning with the delivery precision of the Elekta Versa HD linear accelerator (LINAC). These technologies work in synergy to determine positioning and treatment accuracy for cancer patients.
If you enjoy this content, please share it with a colleague
The U.S. Food and Drug Administration (FDA) released an updated Mammography Quality Standards Act and Program (MQSA) Scorecard, which offers answers to the most commonly requested national statistics regarding the MQSA program. These statistics are updated on the first of each month.
Ion Beam Applications S.A. (IBA) announced the successful expansion of IBA Academy on the Road “Small Field Dosimetry Workshop,” organized and hosted with Lung Center of the Philippines in Manila, and the Philippine Organization of Medical Physicists (POMP) on March 7.
The American Society of Radiologic Technologists (ASRT) has launched Safety Essentials, an online educational series providing healthcare professionals with guidance to create a culture of safety in the workplace.
The U.S. Food and Drug Administration (FDA) reports it has revoked the Mammography Quality Standards Act (MQSA) certificate for AP Diagnostic Imaging Inc., a facility at 1692 Oak Tree Road in Edison, New Jersey. The facility has ceased performing mammography.
A new study published online in the journal Radiology found a substantial gap between patient expectations and current practices for providing information about medical imaging tests that use radiation. Researchers said the findings highlight a need for better communication as medicine enters an era of patient-centered care.
If you enjoy this content, please share it with a colleague